Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery

NCT ID: NCT00719017

Last Updated: 2013-04-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Recent findings have suggested that laparoscopic surgery is safe and effective, as well as laparotomic one, for treating patients with early stage endometrial cancer (ESEC). Moreover, our long-term previous data have shown a trend in vaginal cuff recurrence in subjects who underwent laparoscopic approach to ESEC consisting of extrafascial hysterectomy, bilateral salpingo-oophorectomy, pelvic +/- para-aortic nodes dissections, regardless grading or lymphovascular space invasion.

Based on these considerations, the aim of the current protocol-study will be to compare two different strategies for vaginal cuff recurrences prevention in patients affected by ESEC treated with laparoscopic surgery. In particular, upper vaginectomy followed by observation will be compared to post-operative brachytherapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women with ESEC scheduled for laparoscopic surgery will be enrolled and randomized in three arms \[vaginectomy group (VG), brachytherapy group (BG), and control group (CG)\]. All laparoscopic procedures will consist of total hysterectomy, bilateral salpingo-oophorectomy, peritoneal washing, systematic inspection of peritoneal cavity and biopsy of each suspect lesion, and pelvic (and eventual para-aortic) lymphadenectomy. In VG an upper vaginecomy will be added to standard laparoscopic procedures followed by observation, whereas BG will receive post-operative brachytherapy. CG will be treated with standard protocol for management of ESEC according to National Comprehensive Cancer Network (www.nccn.org).

Safety and efficacy data will be recorded in each group for 24 months of follow-up.

Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less will be considered significant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early Stage Endometrial Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vaginectomy group

Upper vaginectomy

Group Type EXPERIMENTAL

Upper vaginectomy

Intervention Type PROCEDURE

Laparoscopic surgery with upper vaginectomy

Brachytherapy group

Post-operative brachytherapy

Group Type EXPERIMENTAL

Post-operative brachytherapy

Intervention Type RADIATION

Laparoscopic surgery followed by brachytherapy

Control group

Standard treatment

Group Type ACTIVE_COMPARATOR

Standard procedures

Intervention Type PROCEDURE

Laparoscopic surgery +/- brachytherapy +/- pelvic radiation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Upper vaginectomy

Laparoscopic surgery with upper vaginectomy

Intervention Type PROCEDURE

Post-operative brachytherapy

Laparoscopic surgery followed by brachytherapy

Intervention Type RADIATION

Standard procedures

Laparoscopic surgery +/- brachytherapy +/- pelvic radiation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Early stage endometrial cancer

Exclusion Criteria

* Other pre-malignancies and malignancies
* Major medical conditions
* Psychiatric disorders
* Current or past history of acute or chronic physical illness
* Premenstrual syndrome (PMS)
* Current or past (within 6 months from study enrolment) use of drugs influencing cognition, vigilance, and/or mood.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Magna Graecia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stefano Palomba

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stefano Palomba, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro

Fulvio Zullo, MD

Role: STUDY_CHAIR

Department of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

"Pugliese" Hospital

Catanzaro, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stefano Palomba, MD

Role: CONTACT

+39-0961.883234

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ingrid Tomaino, MD

Role: primary

+39 0961 883234

References

Explore related publications, articles, or registry entries linked to this study.

Zullo F, Palomba S, Russo T, Falbo A, Costantino M, Tolino A, Zupi E, Tagliaferri P, Venuta S. A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life. Am J Obstet Gynecol. 2005 Oct;193(4):1344-52. doi: 10.1016/j.ajog.2005.02.131.

Reference Type BACKGROUND
PMID: 16202724 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

03/2007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy of In-bag Morcellation
NCT03281460 COMPLETED NA